Lifecore Biomedical (LFCR) Fundamental Analysis: Revenue, Earnings & Valuation

9.55 / 10

Outperform

Fundamental analysis rates LFCR as Outperform with a 9.55/10 score. Key drivers include PB‑ROE, Cash‑UP and asset turnover, while the high cost‑of‑sales ratio drags performance. Overall fundamentals are robust.

Analysis Checks(9/10)

Profit-MV

Value0.68

Score2/3

Weight2.20%

1M Return0.17%

Net income-Revenue

Value-0.04

Score2/3

Weight-2.83%

1M Return-0.22%

PB-ROE

Value0.20

Score3/3

Weight109.97%

1M Return6.59%

Current assets turnover ratio

Value1.55

Score2/3

Weight8.29%

1M Return0.69%

Cash-UP

Value0.57

Score3/3

Weight39.91%

1M Return2.87%

Total assets turnover ratio

Value0.52

Score3/3

Weight21.02%

1M Return1.82%

Cost of sales ratio (%)

Value68.73

Score0/3

Weight-72.85%

1M Return-7.50%

Asset-MV

Value-0.82

Score2/3

Weight-10.58%

1M Return-0.95%

Inventory turnover days

Value146.88

Score2/3

Weight-4.63%

1M Return-0.39%

Cash-MV

Value-0.82

Score2/3

Weight9.50%

1M Return0.79%

Is LFCR fundamentally strong?

LFCR scores 9.55/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.00% ROE, -30.04% net margin, -3.27 P/E ratio, 3.06 P/B ratio, and 0.00% earnings growth, these metrics solidify its Outperform investment rating.